Literature DB >> 34061767

The metabolic syndrome in pediatrics: do we have a reliable definition? A systematic review.

Angelo Tropeano1, Domenico Corica1, Alessandra Li Pomi1, Giorgia Pepe1, Letteria Anna Morabito1, Selenia Lorenza Curatola1, Celeste Casto1, Tommaso Aversa1, Malgorzata Wasniewska1.   

Abstract

OBJECTIVE: Metabolic syndrome is a cluster of cardio-metabolic risk factors associated with an increased risk of cardiovascular disease and type 2 diabetes. In the last two decades, several definitions of metabolic syndrome have been proposed for the pediatric population; all of them agree on the defining components but differ in the suggested criteria for diagnosis. This review aims to analyze the current diagnostic criteria of metabolic syndrome in pediatrics with reference to their feasibility and reliability in clinical practice.
METHODS: The systematic research was conducted from January 2003 to June 2020 through MEDLINE via PubMed, Cochrane Library and EMBASE databases.
RESULTS: After the selection phase, a total of 15 studies (182 screened) met the inclusion criteria and are reported in the present review. Twelve studies were cross-sectional, two were longitudinal and one was a consensus report. The sample population consisted of multiethnic group or single ethnic group, including Turkish, European, Asian and Hispanic subjects.
CONCLUSIONS: To date, there is not a univocal, internationally accepted pediatric definition of metabolic syndrome, which guarantees a high sensitivity and stability of the diagnosis. The definition proposed by IDF results the most straightforward and easy to use in clinical practice, having the unquestionable advantage of requiring measurements quickly accessible in clinical practice, without the adoption of multiple reference tables. Further research is needed to validate a new version of such definition which includes the diagnostic cut-off points recently suggested by published guidelines.

Entities:  

Mesh:

Year:  2021        PMID: 34061767     DOI: 10.1530/EJE-21-0238

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  3 in total

1.  The effect of obesity-related allostatic changes on cardio-metabolic risk in euthyroid children.

Authors:  A Tropeano; D Corica; S Curatola; A Li Pomi; C Casto; A Alibrandi; G Pepe; T Aversa; M Wasniewska
Journal:  J Endocrinol Invest       Date:  2022-08-20       Impact factor: 5.467

2.  Angiopoietin-Like Proteins 2 and 3 in Children and Adolescents with Obesity and Their Relationship with Hypertension and Metabolic Syndrome.

Authors:  Zahra Arab Sadeghabadi; Mitra Nourbakhsh; Mohammad Alaee; Mona Nourbakhsh; Seyedeh Sara Ghorbanhosseini; Roya Sharifi; Maryam Razzaghy-Azar
Journal:  Int J Hypertens       Date:  2021-08-12       Impact factor: 2.420

3.  High Prevalence of Cardiometabolic Comorbidities Among Children and Adolescents With Severe Obesity From a Large Metropolitan Centre (Hangzhou, China).

Authors:  Jinling Wang; Hu Lin; Valentina Chiavaroli; Binghan Jin; Jinna Yuan; Ke Huang; Wei Wu; Guanping Dong; José G B Derraik; Junfen Fu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-19       Impact factor: 6.055

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.